Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best BPC-157 Dosage Muscle Recovery 2026: Protocol Comparison

The table below compares the three most common BPC-157 dosing protocols used in research and athletic recovery contexts, with practical assessment of each approach. Conservative Standard 200–300 mcg Once daily (morning or pre-bed) 4–6 weeks Moderate. Multiple

This comparison does not assign a generated winner or score.

  • The table below compares the three most common BPC-157 dosing protocols used in research and athletic recovery contexts, with practical assessment of each approach.
  • Conservative Standard
  • 200–300 mcg
  • Once daily (morning or pre-bed)
  • 4–6 weeks
  • Moderate. Multiple animal studies, limited human data
  • Best for first-time users or minor soft tissue strains; lower dose reduces GI side effect risk while still providing measurable collagen synthesis benefit
  • Split-Dose Intensive
  • 400–500 mcg
  • Twice daily (morning + evening)
  • 2–4 weeks
  • Strong in animal models, anecdotal in human use
  • Preferred for acute injuries requiring maximum angiogenic response; split dosing maintains more stable plasma levels given 4–6 hour half-life
  • Pulsed High-Dose
  • 500–750 mcg
  • Once daily
  • 1–2 weeks, then taper to 250 mcg
  • Weak. Limited published data at this range
  • Used in severe acute trauma cases; theoretical benefit from saturating growth hormone receptors but no evidence that doses above 500 mcg produce proportional improvement
  • Maintenance Low-Dose
  • 100–200 mcg
  • Once daily or every other day
  • Ongoing (8+ weeks)
  • Minimal. Primarily anecdotal
  • Sometimes used for chronic tendinopathy or general recovery support; questionable cost-benefit ratio given lack of evidence for low-dose chronic administration
More references

Related material